These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9605502)

  • 1. Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals.
    Hernáez ML; Gil C; Pla J; Nombela C
    Yeast; 1998 Apr; 14(6):517-26. PubMed ID: 9605502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
    Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Calabrese D; Bille J; Sanglard D
    Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
    Sanglard D; Ischer F; Monod M; Bille J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
    Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
    Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR; Tsao S; Ong SW; Lamping E; Niimi K; Monk BC; Niimi M; Kaneko A; Holland BR; Schmid J; Cannon RD
    Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole.
    Whaley SG; Tsao S; Weber S; Zhang Q; Barker KS; Raymond M; Rogers PD
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6060-6. PubMed ID: 27480868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones.
    Krishnamurthy S; Gupta V; Prasad R; Panwar SL; Prasad R
    FEMS Microbiol Lett; 1998 Mar; 160(2):191-7. PubMed ID: 9532737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
    Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
    Shen H; An MM; Wang de J; Xu Z; Zhang JD; Gao PH; Cao YY; Cao YB; Jiang YY
    Biol Pharm Bull; 2007 Jan; 30(1):68-73. PubMed ID: 17202662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA; Manoharlal R; Saini P; Prasad T; Mukhopadhyay G; Hoefer M; Morschhäuser J; Prasad R
    Biochem Biophys Res Commun; 2005 Jun; 332(1):206-14. PubMed ID: 15896319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y; Liu JY; Shi C; Li WJ; Zhao Y; Yan L; Xiang MJ
    Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.